• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[PAFAC Study. Secondary prevention of atrial fibrillation after cardioversion].

作者信息

Nitschmann S, Antz M, Kuck K-H

出版信息

Internist (Berl). 2005 Jul;46(7):800-2. doi: 10.1007/s00108-005-1421-x.

DOI:10.1007/s00108-005-1421-x
PMID:15947902
Abstract
摘要

相似文献

1
[PAFAC Study. Secondary prevention of atrial fibrillation after cardioversion].[PAFAC研究。心脏复律后心房颤动的二级预防]
Internist (Berl). 2005 Jul;46(7):800-2. doi: 10.1007/s00108-005-1421-x.
2
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.心脏复律后房颤的预防：PAFAC试验结果
Eur Heart J. 2004 Aug;25(16):1385-94. doi: 10.1016/j.ehj.2004.04.015.
3
[Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].[慢性心房颤动电复律后的药物预防。PAFAC研究的目标与设计]
Z Kardiol. 1999 Mar;88(3):195-207. doi: 10.1007/s003920050276.
4
Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.房颤药物复律的疗效及促心律失常风险：索他洛尔与奎尼丁的前瞻性比较
J Am Coll Cardiol. 1995 Oct;26(4):852-8. doi: 10.1016/0735-1097(95)00286-5.
5
[Atrial fibrillation successfully converted. A new standard in the prevention of recurrence?].[心房颤动成功转复。预防复发的新标准？]
MMW Fortschr Med. 2001 Dec 13;143(51-52):10-2.
6
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Eur Heart J. 2004 Dec;25(23):2174; author reply 2174-5. doi: 10.1016/j.ehj.2004.08.022.
7
Effect of verapamil on secondary cardioversion in patients with early atrial fibrillation recurrence after electrical cardioversion.
Am J Cardiol. 2002 Jul 15;90(2):185-7. doi: 10.1016/s0002-9149(02)02450-5.
8
Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.胺碘酮与索他洛尔及普罗帕酮预防心脏内复律后房颤即刻复发的比较：P波分析的重要性
Int J Cardiol. 2006 Jan 13;106(2):268-9. doi: 10.1016/j.ijcard.2004.12.073.
9
Quinidine plus verapamil vs. quinidine alone to prevent recurrences of atrial fibrillation.奎尼丁加维拉帕米与单用奎尼丁预防心房颤动复发的比较。
Eur Heart J. 2005 Aug;26(15):1568-9. doi: 10.1093/eurheartj/ehi324. Epub 2005 May 17.
10
[Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].症状性阵发性心房颤动/心房扑动发作的药物预防。SOPAT研究的目标与设计。代表试验医师的研究者执行委员会
Z Kardiol. 1999 Mar;88(3):185-94. doi: 10.1007/s003920050275.

本文引用的文献

1
Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation.围绕肺静脉的左心房完全隔离：阵发性心房颤动中双套索技术的新见解
Circulation. 2004 Oct 12;110(15):2090-6. doi: 10.1161/01.CIR.0000144459.37455.EE. Epub 2004 Oct 4.
2
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.用于治疗心房颤动的“早期”Ⅲ类药物：AVE0118在山羊重构心房中的疗效及心房选择性
Circulation. 2004 Sep 28;110(13):1717-24. doi: 10.1161/01.CIR.0000143050.22291.2E. Epub 2004 Sep 13.
3
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
心房颤动节律管理随访研究（AFFIRM）中窦性心律、治疗与生存之间的关系。
Circulation. 2004 Mar 30;109(12):1509-13. doi: 10.1161/01.CIR.0000121736.16643.11. Epub 2004 Mar 8.
4
Rhythm versus rate control trials in atrial fibrillation.
J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S35-9. doi: 10.1046/j.1540-8167.14.s9.17.x.
5
Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.房颤环肺静脉消融术后的死亡率、发病率及生活质量：一项非随机对照长期研究的结果
J Am Coll Cardiol. 2003 Jul 16;42(2):185-97. doi: 10.1016/s0735-1097(03)00577-1.
6
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.美国心脏病学会/美国心脏协会/欧洲心脏病学会心房颤动患者管理指南：执行摘要 美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南与政策会议委员会（心房颤动患者管理指南制定委员会）联合北美心脏起搏与电生理学会制定的报告
Circulation. 2001 Oct 23;104(17):2118-50.
7
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.起源于肺静脉的异位搏动自发引发心房颤动。
N Engl J Med. 1998 Sep 3;339(10):659-66. doi: 10.1056/NEJM199809033391003.